High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia.
Dávila Saldaña BJ, John T, Bonifant C, Buchbinder D, Chandra S, Chandrakasan S, Chang W, Chen L, Elfassy HL, Geerlinks AV, Giller RH, Goyal R, Hagin D, Islam S, Mallhi K, Miller HK, Owen W, Pacheco M, Patel NC, Querfeld C, Quigg T, Richard N, Schiff D, Shereck E, Stenger E, Jordan MB, Heslop HE, Bollard CM, Cohen JI.
Dávila Saldaña BJ, et al. Among authors: giller rh.
Blood Adv. 2022 Jan 25;6(2):452-459. doi: 10.1182/bloodadvances.2021005291.
Blood Adv. 2022.
PMID: 34670275
Free PMC article.